LOS ANGELES, June 11, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) announced today that a Scientific Advisory Board (SAB) has been established to guide progress for the company’s BG Vision and BG Health Services programs. The function of the SAB is to provide advice and guidance in developing new solutions for natural medicinal production, diagnostic device design, and telehealth naturopathy services. The initial focus of the SAB will be on technology acquisitions to facilitate Internet-based solutions for the 50 million uninsured patients in the USA, and patients looking to augment traditional health care packages with cost effective nature-based practices.
BG Medical Technologies is pleased to announce that technology expert and pioneer in the vertical farming industry, Nick Brusatore, has agreed to join the SAB.
Mr. Brusatore is the CEO of Vertical Designs, Ltd., a firm for designing vertical farming technologies related to food and natural medicine production. Nick is the designer of TerraSphere systems and several well-established technologies for cloning and plant tissue propagation. He is an innovative eco-entrepreneur, natural capitalist, mechanical designer, and inventor. Nick has presented on the benefits of vertical farm production facilities and energy saving technologies upon the international stage, including Vancouver, Haiti, New York, and various college universities. Mr. Brusatore also serves as the Chairman of the British Columbia Institute of Technology’s Centre for Applied Research and Innovation Advisory Committee.
“BGMT is creating a world-class think tank of leaders in green health technologies,” commented Angel Stanz, CEO. “Mr. Brusatore will lend his experience and thought leadership in selecting and improving the best available technologies for use in our naturopathy health care systems, natural medicine, and nutraceutical production.”
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for natural health treatment, patients, and professionals, including its flagship research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management’s expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Angel Stanz
Chief Executive Officer
pr(at)bgmedtech(dot)com
(855) 723-3283
SOURCE BG Medical Technologies, Inc.
